The present invention is in the field of molecular biology and biotechnology. In particular, the invention concerns the specific gene expression in ASCL2-positive cells. The present invention further relates to methods for the diagnosis and treatment of cancers, preferably intestinal (small and large), lung, stomach or breast cancer, preferably colorectal cancer, preferably wherein cancer stem cells (CSCs) are marked by ASCL2. Specifically, the invention relates to a method to report and/or manipulate cancer stem cell activity in human colon organoids. Ian Bell ian.bell@oncode.nl +31628374976
Smart, interactive desk
May 8, 2023
No Comments
Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the